Physician profile
Scott D Friedman
NPI 1154485811
$8,774.28
in general payments reported to CMS, 2019-2025
40 companies · $1,388 in 2025
The $1,388 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,624 · 2020: $1,858 · 2021: $943 · 2022: $1,053 · 2023: $724 · 2024: $1,184 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984 · Education: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,983.96 |
| Education | $312.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $1,751.20 | 2019-2022 | |
| Abbvie INC. | $1,425.66 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,011.85 | 2019-2025 | |
| Janssen Biotech, INC. | $1,002.31 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Galderma Laboratories, L.P. | $403.05 | 2024-2025 | Nemluvio, Aklief |
| Regeneron Healthcare Solutions, INC. | $282.82 | 2019-2025 | Dupixent, Libtayo |
| Pfizer INC. | $281.09 | 2019-2025 | |
| Journey Medical Corporation | $258.92 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $247.13 | 2019-2025 | |
| Merz North America, INC. | $201.78 | 2019 | |
| Epi Health, LLC | $182.58 | 2019-2021 | |
| Ucb, INC. | $177.08 | 2021-2025 | Bimzelx |
| Genentech USA, INC. | $174.39 | 2019-2024 | Erivedge |
| Vyne Pharmaceuticals INC. | $157.00 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $140.72 | 2022-2024 | Sotyktu |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.